experience to date in more than 300 patients suggests that suppression of inducible ventricular arrhythmias by mexiletine either alone or in combination with another antiarrhythmic agent may be achieved in approximately 30 % of patients .
C0025887
mexiletine
C0003195
antiarrhythmic agent